E-LIB Suche - Ergebnisse für: Rawson, Nigel S. B.

1

Orphan drugs approved in Canada: health technology assessme..:

Rawson, Nigel S B. ; Adams, John
Expert Opinion on Orphan Drugs. 12 (2024) 1 - p. 1-11 , 2024

Link: https://doi.org/10.1080/..

2

New Anticancer Drugs: Reliably Assessing "Value" While Addr..:

Stewart, David J. ; Bradford, John-Peter ; Sehdev, Sandeep...
Current Oncology. 31 (2024) 5 - p. 2453-2480 , 2024

Link: https://doi.org/10.3390/..

3

Access to Oncology Medicines in Canada: Consensus Forum for..:

Sehdev, Sandeep R. ; Rawson, Nigel S. B. ; Aseyev, Olexiy I....
Current Oncology. 31 (2024) 4 - p. 1803-1816 , 2024

Link: https://doi.org/10.3390/..

4

Health technology assessment and price negotiation alignmen..:

Rawson, Nigel S. B.
Orphanet Journal of Rare Diseases. 17 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

5

Leading Causes of Mortality and Prescription Drug Coverage ..:

Rawson, Nigel S. B.
Frontiers in Public Health. 8 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

6

Comparison of numbers and timing of new medication regulato..:

Rawson, Nigel S.B.
Regulatory Toxicology and Pharmacology. 101 (2019) - p. 24-28 , 2019

Link: https://doi.org/10.1016/..

7

LETTER TO THE EDITOR:

Rawson, Nigel S.B.
Journal of Population Therapeutics and Clinical Pharmacology. 26 (2019) 1 - p. e20-e21 , 2019

Link: https://doi.org/10.22374..

8

Healthcare Databases for Drug Safety Research: Data Validit..:

Rawson, Nigel S. B. ; D'Arcy, Carl
Drug Safety. 41 (2018) 9 - p. 829-833 , 2018

Link: https://doi.org/10.1007/..

9

Canadian, European and United States new drug approval time..:

Rawson, Nigel S.B.
Regulatory Toxicology and Pharmacology. 96 (2018) - p. 121-126 , 2018

Link: https://doi.org/10.1016/..

10

Health technology assessment of new drugs for rare disorder..:

Rawson, Nigel S. B.
Orphanet Journal of Rare Diseases. 12 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

11

Drug safety: withdrawn medications are only part of the pic..:

Rawson, Nigel S. B.
BMC Medicine. 14 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

12

Health Canada's use of priority review status for drugs for..:

Rawson, Nigel S.B.
Regulatory Toxicology and Pharmacology. 73 (2015) 1 - p. 391-395 , 2015

Link: https://doi.org/10.1016/..

13

Access to linked administrative healthcare utilization data..:

Rawson, Nigel S. B.
Pharmacoepidemiology and Drug Safety. 18 (2009) 11 - p. 1072-1079 , 2009

Link: https://doi.org/10.1002/..

14

Manitoba and Saskatchewan administrative health care utiliz..:

Tricco, Andrea C. ; Pham, Ba' ; Rawson, Nigel S.B.
Journal of Clinical Epidemiology. 61 (2008) 2 - p. 192-197.e12 , 2008

Link: https://doi.org/10.1016/..

15

Lessons for a national pharmaceuticals strategy in Canada f..:

LeLorier, Jacques ; Rawson, Nigel S.B.
Canadian Journal of Cardiology. 23 (2007) 9 - p. 711-718 , 2007

Link: https://doi.org/10.1016/..